Aktiespot

TherapeuticsMD, Inc. Aktie

TXMD

Pre-market
$2.1200-0.0200 (-0.93%)
Pre-Market:$2.0400-0.08 (-3.77%)
Chart wird geladen...

TherapeuticsMD, Inc.

Eröffnung2.0400
Hoch2.1200
Tief2.0200
Volumen14.82k
P/E212.00
Marktkapitalisierung24.54M
52-Wochen-Hoch2.9500
52-Wochen-Tief0.9800
Durchschn. Volumen21.68k
DividendeN/A
BetaN/A
EPS0.0100

Über TherapeuticsMD, Inc. Aktie

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Unternehmensinformationen

Börse: NasdaqGS (NMS)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
951 Yamato Road
33431 Boca Raton, United States
Telefon: + 561-961-1900

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: